Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Ascelia Pharma – Presentation of Full-Year report 2023

By HC Andersen Capital
09.02.2024, 11.30
Ascelia Pharma

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Meet and ask questions to CEO Magnus Corfitzen from Ascelia Pharma on 9 February at 11:30 AM.

The topic for this event is the Q4 and Full-Year report and major events during the last quarter in 2023. In Q4, Ascelia Pharma announced a re-start of the Imaging Reading Phase and re-confirmed Phase 3 SPARKLE results by May 2024. Ascelia Pharma will update the investor community on the roll-out strategy for Orviglance to the market.

Ascelia Pharma is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. Ascelia Pharma has two drug candidates – Orviglance® (Mangoral) and Oncoral – in clinical development. Ascelia Pharma has its global headquarters in Malmö, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE).

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 12/1/2024 09.03 AM.

Recent videos

Gr
GreenMobility – Presentation of H1 Interim Report 2025
19.08.2025, 13.30 GreenMobility
RG
Relais: The acceleration lane is still open
19.08.2025, 11.20 Relais Group
DR
Donkey Republic – Presentation of H1 2025
19.08.2025, 10.00 Donkey Republic
VG
Verve Group, Capital Markets Day, Q2'25
19.08.2025, 10.00 Verve Group
BICO
BICO, Audiocast, Q2'25
19.08.2025, 10.00 BICO Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.